Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.
1. Molecules. 2023 May 19;28(10):4197. doi: 10.3390/molecules28104197. Enhancement of Inhibitory Activity by Combining Allosteric Inhibitors Putatively Binding to Different Allosteric Sites on Cathepsin K. Sato S(1), Yamamoto K(1), Ito M(1), Nishino K(1), Otsuka T(2), Irie K(3), Nagao M(1). Author information: (1)Graduate School of Biostudies, Kyoto University, Kyoto 606-8502, Japan. (2)Department of Applied Chemistry and Biotechnology, Okayama University of Science, Okayama 700-0005, Japan. (3)Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan. BACKGROUND: Cathepsin K, which is involved in bone resorption, is a good target for treating osteoporosis, but no clinically approved medicine has been developed. Recently, allosteric inhibitors with high specificity and few side effects have been attracting attention for use in new medicines. METHODS: Cathepsin K inhibitors were isolated from the methanol extract of Chamaecrista nomame (Leguminosae) using cathepsin K inhibition activity-assisted multi-step chromatography. Standard kinetic analysis was employed to examine the mechanism of cathepsin K inhibition when an isolated inhibitor and its derivative were used. The allosteric binding of these cathepsin K inhibitors was supported by a docking study using AutoDock vina. Combinations of allosteric cathepsin K inhibitors expected to bind to different allosteric sites were examined by means of cathepsin K inhibition assay. RESULTS: Two types of cathepsin K inhibitors were identified in the methanol extract of Chamaecrista nomame. One type consisted of cassiaoccidentalin B and torachrysone 8-β-gentiobioside, and inhibited both cathepsin K and B with similar inhibitory potential, while the other type of inhibitor consisted of pheophytin a, and inhibited cathepsin K but not cathepsin B, suggesting that pheophytin a binds to an allosteric site of cathepsin K. Kinetic analysis of inhibitory activity suggested that pheophytin a and its derivative, pheophorbide b, bind allosterically to cathepsin K. This possibility was supported by a docking study on cathepsin K. The cathepsin K inhibitory activity of pheophytin a and pheophorbide b was enhanced by combining them with the allosteric inhibitors NSC 13345 and NSC94914, which bind to other allosteric sites on cathepsin K. CONCLUSIONS: Different allosteric inhibitors that bind to different sites in combination, as shown in this study, may be useful for designing new allosteric inhibitory drugs with high specificity and few side effects. DOI: 10.3390/molecules28104197 PMCID: PMC10221639 PMID: 37241936 [Indexed for MEDLINE] Conflict of interest statement: The authors declare no conflict of interest. 2. RSC Adv. 2021 Dec 9;11(62):39362-39375. doi: 10.1039/d1ra07661b. eCollection 2021 Dec 6. Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics. Dwivedi PSR(1), Patil R(2), Khanal P(3), Gurav NS(4), Murade VD(5), Hase DP(6), Kalaskar MG(7), Ayyanar M(8), Chikhale RV(9), Gurav SS(10). Author information: (1)Department of Pharmacology, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University) Mangalore-575018 India. (2)Sinhgad Technical Education Society's, Sinhgad College of Pharmacy Vadgaon (Bk) Pune-411041 Maharashtra India. (3)Department of Pharmacology and Toxicology, KLE College of Pharmacy Belagavi, KLE Academy of Higher Education and Research (KAHER) Belagavi-590010 India pukarkhanal58@gmail.com. (4)Ponda Education Society's Rajaram and Tarabai Bandekar College of Pharmacy India. (5)Department of Chemistry, Padmashri Vikhe Patil College Pravarangar, Loni Ahmednagar Maharashtra India. (6)Department of Pharmacognosy, Amrutvahini College of Pharmacy Sangamner Maharashtra India. (7)R C Patel Institute of Pharmaceutical Education and Research Shirpur India. (8)Department of Botany, A. V. V. M. Sri Pushpam College (Autonomous), Affiliated to Bharathidasan University Poondi Thanjavur India. (9)School of Pharmacy, University of East Anglia Norwich Research Park Norwich UK rupeshchikhale7@gmail.com. (10)Department of Pharmacognosy and Phytochemistry, Goa College of Pharmacy Panaji, Goa University Goa-403001 India shailendra.gurav@nic.in. Cassia glauca is reported as anti-diabetic medicinal plant and is also used as an ethnomedicine. However, its mode of action as an anti-diabetic agent has not been clearly elucidated. Hence, the present study investigated the probable mechanism of action of C. glauca to manage diabetes mellitus via network pharmacology and molecular docking and simulations studies. The reported bioactives from C. glauca were retrieved from an open-source database, i.e. ChEBI, and their targets were predicted using SwissTargetPrediction. The proteins involved in the pathogenesis of diabetes were identified from the therapeutic target database. The targets involved in diabetes were enriched in STRING, and the pathways involved in diabetes were identified concerning the KEGG. Cytoscape was used to construct the network among bioactives, proteins, and probably regulated pathways, which were analyzed based on edge count. Similarly, molecular docking was performed using the Glide module of the Schrodinger suite against majorly targeted proteins with their respective ligands. Additionally, the drug-likeness score and ADMET profile of the individual bioactives were predicted using MolSoft and admetSAR2.0 respectively. The stability of these complexes were further studied via molecular dynamics simulations and binding energy calculations. Twenty-three bio-actives were retrieved from the ChEBI database in which cassiarin B was predicted to modulate the highest number of proteins involved in diabetes mellitus. Similarly, GO analysis identified the PI3K-Akt signaling pathway to be primarily regulated by modulating the highest number of gene. Likewise, aldose reductase (AKR1B1) was majorly targeted via the bioactives of C. glauca. Similarly, docking study revealed methyl-3,5-di-O-caffeoylquinate (docking score -9.209) to possess the highest binding affinity with AKR1B1. Additionally, drug-likeness prediction identified cassiaoccidentalin B to possess the highest drug-likeness score, i.e. 0.84. The molecular dynamics simulations and the MMGBSA indicate high stability and greater binding energy for the methyl-3,5-di-O-caffeoylquinate (ΔG bind = -40.33 ± 6.69 kcal mol-1) with AKR1B1, thus complementing results from other experiments. The study identified cassiarin B, cassiaoccidentalin B, and cinnamtannin A2 as lead hits for the anti-diabetic activity of C. glauca. Further, the PI3K-Akt and AKR1B1 were traced as majorly modulated pathway and target, respectively. This journal is © The Royal Society of Chemistry. DOI: 10.1039/d1ra07661b PMCID: PMC9044434 PMID: 35492478 Conflict of interest statement: All the authors of this manuscript have no conflict of interest in any financial and non-financial means. 3. J Ethnopharmacol. 2021 Nov 15;280:114470. doi: 10.1016/j.jep.2021.114470. Epub 2021 Jul 27. Inhibition of α-glucosidase by flavonoids of Cymbopogon citratus (DC) Stapf. Borges PHO(1), Pedreiro S(2), Baptista SJ(3), Geraldes CFGC(4), Batista MT(5), Silva MMC(6), Figueirinha A(7). Author information: (1)University of Coimbra, Faculty of Pharmacy of University of Coimbra, Coimbra, Portugal. (2)University of Coimbra, Faculty of Pharmacy of University of Coimbra, Coimbra, Portugal; LAQV, REQUIMTE, Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal. (3)Center for Nuclear Sciences and Technologies, Instituto Superior Técnico, University of Lisbon, Portugal; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal. (4)Department of Life Sciences, Faculty of Science and Technology, University of Coimbra, Coimbra, Portugal; Coimbra Chemistry Center, Faculty of Science and Technology, University of Coimbra, Coimbra, Portugal. (5)University of Coimbra, Faculty of Pharmacy of University of Coimbra, Coimbra, Portugal; CIEPQPF, Department of Chemical Engineering, Faculty of Science and Technology, University of Coimbra, 3030-790, Coimbra, Portugal. (6)University of Coimbra, Faculty of Pharmacy of University of Coimbra, Coimbra, Portugal; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal. Electronic address: msilva@ff.uc.pt. (7)University of Coimbra, Faculty of Pharmacy of University of Coimbra, Coimbra, Portugal; LAQV, REQUIMTE, Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal. Electronic address: amfigueirinha@ff.uc.pt. ETHNOPHARMACOLOGICAL RELEVANCE: Leaves extracts from Cymbopogon citratus (DC) Stapf. are widely used in traditional medicine exhibiting several in vivo biological activities, including antidiabetic. Several flavonoids, including aglycones and glycosides, were reported in this plant and previous studies suggested that flavonoids may interact with targets related to diabetes. AIM OF THE STUDY: Evaluated the hypoglycemic activity of C. citratus flavonoids through α-glucosidase inhibition and assess the structure-activity relationship using molecular docking studies. MATERIAL AND METHODS: An infusion of C. citratus leaves and its flavonoid-rich fraction were prepared. Five flavonoids from this fraction were isolated and structurally characterized by UV spectral analysis with shift reagents, HPLC-PDA-ESI/MSn and 1H NMR. The antidiabetic potential of C. citratus infusion, its flavonoid-rich fraction, glycosylated flavonoids and aglycones was evaluated trough the in vitro inhibition of yeast α-glucosidase. Posteriorly, molecular docking of the tested flavonoids was performed to investigate its possible interactions with the α-glucosidase pocket. RESULTS: The infusion of C. citratus, its flavonoid-rich fraction, luteolin and five flavone glycosides namely, luteolin 6-C-β-glucopyranoside (isoorientin), luteolin 7-O-neohesperidoside (ionicerin), luteolin 7-O-β-glucopyranoside (cynaroside), Luteolin 2″-O-rhamnosyl-C-(6-deoxy-ribo-hexos-3-ulosyl) (cassiaoccidentalin B), luteolin 6-C-α-arabinofuranosil-(1→2)-α-L-rhamnopyranoside (kurilesin A) showed higher inhibitory activity than the reference drug. This activity increased by the addition of a sugar moiety. However, the di-glycosides were less active than mono-glycosides. The docking studies showed interactions of sugar moieties and A or B rings with the catalytic pocket mainly through hydrogen bonds. CONCLUSIONS: Our results corroborate the potential of C. citratus as a medicinal plant for the treatment of diabetes and revealed that its flavonoid glycosides has hypoglycemic effect and can be explored as drug candidates to act as α-glucosidase inhibitors in the treatment of diabetes. Copyright © 2021. Published by Elsevier B.V. DOI: 10.1016/j.jep.2021.114470 PMID: 34329713 [Indexed for MEDLINE] 4. J Diabetes Metab Disord. 2020 May 28;19(2):683-689. doi: 10.1007/s40200-020-00538-9. eCollection 2020 Dec. Gene set enrichment analysis of α-amylase and α-glucosidase inhibitors of Cassia glauca. Ternikar SG(1), Patil MB(2), Pasha I(3), Khanal P(4). Author information: (1)Sant Gajanan Maharaj College of Pharmacy Mahagaon, Maharashtra, India. (2)Department of Pharmacognosy and Phytochemistry, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER), Belagavi, 590010 India. (3)Department of Pharmacology, Orotta College of Medicine and Health Sciences, Asmara University, Asmara, Eritrea. (4)Department of Pharmacology and Toxicology, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER), Belagavi, 590010 India. BACKGROUND: The present study aimed to evaluate in vitro α-amylase and α-glucosidase inhibitory activity of various extracts of Cassia glauca, predict the binding affinity of multiple phytoconstituents with both enzymes via in silico molecular docking and identify the probably modulated pathways by the lead hit. METHODS: Different extracts of Cassia glauca i.e. acetone, ethanol, and aqueous extracts were evaluated for α-amylase and α-glucosidase inhibitory activity using in vitro method in which starch and 4-Nitrophenyl β-D-glucopyranoside were used as substrate respectively. Similarly, the docking study was performed using autodock4 to predict the binding affinity of phytoconstituents with α-amylase and α-glucosidase. After docking, ten different poses were obtained for the ligand molecule. Among them, the pose of ligand molecule with the lowest binding energy was visualized in Discovery Studio 2019. RESULTS AND CONCLUSION: Among the multiple extracts, the aqueous extract showed the highest α-amylase (IC50:652.10 ± 20.09) and α-glucosidase (IC50:482.46 ± 8.70) inhibitory activity. Similarly, cassiaoccidentalin B was predicted to have the highest binding affinity with both enzymes. The potency of aqueous extract to inhibit α-amylase and α-glucosidase could be due to multiple water-soluble compounds like saponins, flavonoids, and glycosides. © Springer Nature Switzerland AG 2020. DOI: 10.1007/s40200-020-00538-9 PMCID: PMC7843725 PMID: 33520796 Conflict of interest statement: Conflict of interestThe authors declared that they have no conflict of interest 5. J Ethnopharmacol. 2016 Feb 3;178:222-8. doi: 10.1016/j.jep.2015.12.016. Epub 2015 Dec 17. Polyphenols from Cymbopogon citratus leaves as topical anti-inflammatory agents. Costa G(1), Ferreira JP(2), Vitorino C(2), Pina ME(3), Sousa JJ(2), Figueiredo IV(4), Batista MT(2). Author information: (1)Center for Pharmaceutical Studies, Faculty of Pharmacy, University of Coimbra, Portugal; Center for Neurosciences and Cell Biology, University of Coimbra, Portugal. Electronic address: costagff@gmail.com. (2)Center for Pharmaceutical Studies, Faculty of Pharmacy, University of Coimbra, Portugal; Center for Neurosciences and Cell Biology, University of Coimbra, Portugal. (3)CIEPQPF, Research Center for Chemical Processes Engineering and Forest Products, Chemical Engineering Department, Faculty of Sciences and Technology, University of Coimbra, Portugal. (4)Center for Pharmaceutical Studies, Faculty of Pharmacy, University of Coimbra, Portugal; Institute for Biomedical Imaging and Life Sciences, University of Coimbra, Portugal. ETHNOPHARMACOLOGICAL RELEVANCE: A variety of plant polyphenols have been reported to have anti-inflammatory, frequently associated with erythema, edema, hyperplasia, skin photoaging and photocarcinogenesis. Cymbopogon citratus (DC). Stapf (Poaceae) is a worldwide known medicinal plant, used in traditional medicine in inflammation-related conditions. AIM OF THE STUDY: In this work, the anti-inflammatory potential of C. citratus infusion (CcI) and its polyphenols as topical agents was evaluated in vivo. MATERIALS AND METHODS: The plant extract was prepared and its fractioning led two polyphenol-rich fractions: flavonoids fraction (CcF) and tannins fraction (CcT). An oil/water emulsion was developed with each active (CcI, CcF+CcT and diclofenac), pH and texture having been evaluated. Release tests were further performed using static Franz diffusion cells and all collected samples were monitored by HPLC-PDA. In vivo topical anti-inflammatory activity evaluation was performed by the carrageenan-induced rat paw edema model. RESULTS: The texture analysis revealed statistically significant differences for all tested parameters to CcF+CcT, supporting its topical application. Release experiments lead to the detection of the phenolic compounds from each sample in the receptor medium and the six major flavonoids were quantified, by HPLC-PDA: carlinoside, isoorientin, cynaroside, luteolin 7-O-neohesperidoside, kurilesin A and cassiaoccidentalin B. The CcF+CcT formulation prompted to the higher release rate for all these flavonoids. CcI4%, CcI1% and CcF+CcT exhibited an edema reduction of 43.18, 29.55 and 59.09%, respectively. CONCLUSIONS: Our findings highlight that CcI, containing luteolin 7-O-neohesperidoside, cassiaoccidentalin B, carlinoside, cynaroside and tannins have a potential anti-inflammatory topical activity, suggesting their promising application in the treatment of skin inflammatory pathologies. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved. DOI: 10.1016/j.jep.2015.12.016 PMID: 26702504 [Indexed for MEDLINE]